Page last updated: 2024-12-07
benzoylamidoacetonitrile
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
benzamidoacetonitrile: a powerful competitive inhibitor of papain [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 101372 |
CHEMBL ID | 1950251 |
SCHEMBL ID | 2863808 |
MeSH ID | M0043552 |
Synonyms (24)
Synonym |
---|
n-(cyanomethyl)benzamide |
5692-27-3 |
hippuronitrile |
nsc408922 |
benzamidoacetonitrile |
nsc-408922 |
STK064512 |
AKOS000268428 |
benzoylamidoacetonitrile |
6fbv0ymd6u , |
unii-6fbv0ymd6u |
benzamide, n-(cyanomethyl)- |
nsc 408922 |
CHEMBL1950251 |
SCHEMBL2863808 |
benzoylaminoacetonitrile |
n-(cyanomethyl)benzamide # |
n-(cyanomethyl)benzamid |
DTXSID90205466 |
mfcd01212017 |
benzamide, n-(cyanomethyl)- (6ci,7ci,8ci,9ci) |
(benzoylamino)acetonitrile |
2-benzamidoacetonitrile |
PD138384 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (15)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID647096 | Inhibition of papaya papain using methyl hippurate as substrate by titrimetric method | 2011 | Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23 | Design, synthesis and biological evaluation of peptidyl-vinylaminophosphonates as novel cysteine protease inhibitors. |
AID1160967 | Inhibition of Bovine thrombin using Boc-Val-Pro-Arg-AMC as substrate compound preincubated at 25 uM for 15 mins by fluorescence assay | 2014 | Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18 | Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. |
AID1160966 | Inhibition of West Nile virus NS2B-NS3 protease at 50 uM | 2014 | Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18 | Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. |
AID1160970 | Inhibition of wild-type Escherichia coli MurA compound preincubated for 10 mins before substrate addition at 25 uM measured after 15 mins by LC-MS method | 2014 | Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18 | Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. |
AID1332119 | Inhibition of Trypanosoma brucei rhodesain using Cbz-Phe-Arg-AMC as substrate at 20 uM by fluorescence-based assay | 2017 | Bioorganic & medicinal chemistry letters, 01-01, Volume: 27, Issue:1 | Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei. |
AID1160974 | Inhibition of wild-type Escherichia coli MurE compound preincubated for 10 mins before substrate addition at 25 uM measured after 15 mins by LC-MS method | 2014 | Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18 | Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. |
AID1160981 | Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 24 hrs by CellTiter-Blue assay | 2014 | Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18 | Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. |
AID1160972 | Inhibition of wild-type Escherichia coli MurC compound preincubated for 10 mins before substrate addition at 25 uM measured after 15 mins by LC-MS method | 2014 | Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18 | Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. |
AID1160971 | Inhibition of wild-type Escherichia coli MurB compound preincubated for 10 mins before substrate addition at 25 uM measured after 15 mins by LC-MS method | 2014 | Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18 | Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. |
AID1160968 | Inhibition of Escherichia coli MetAP at 25 uM after 20 mins by HPLC analysis | 2014 | Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18 | Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. |
AID1160973 | Inhibition of wild-type Escherichia coli MurD compound preincubated for 10 mins before substrate addition at 25 uM measured after 15 mins by LC-MS method | 2014 | Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18 | Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. |
AID1160969 | Inhibition of human MetAP at 25 uM after 20 mins by HPLC analysis | 2014 | Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18 | Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. |
AID1160965 | Inhibition of Dengue virus serotype 2 NS2B-NS3 protease at 50 uM | 2014 | Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18 | Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. |
AID1160976 | GSH reactivity of the compound assessed as adducts formation by RP-HPLC analysis | 2014 | Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18 | Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. |
AID1160975 | Inhibition of wild-type Escherichia coli MurF compound preincubated for 10 mins before substrate addition at 25 uM measured after 15 mins by LC-MS method | 2014 | Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18 | Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.27
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.27) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |